A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : AA / arachidonate

[Related PubMed/MEDLINE]
Total Number of Papers: 93
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   AA  (>> Co-occurring Abbreviation)
Long Form:   arachidonate
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2018 An overview of the biologic effects of omega-6 oxylipins in humans. LA, PUFA
2016 Calcium-independent phospholipases A2 in murine osteoblastic cells and their inhibition by bromoenol lactone: impact on arachidonate dynamics and prostaglandin synthesis. BEL, PG
2014 Docosahexaenoyl ethanolamide improves glucose uptake and alters endocannabinoid system gene expression in proliferating and differentiating C2C12 myoblasts. 2-AG, AEA, DHA, DHEA, ECS, PUFA
2014 Pro-oxidant activity of indicaxanthin from Opuntia ficus indica modulates arachidonate metabolism and prostaglandin synthesis through lipid peroxide production in LPS-stimulated RAW 264.7 macrophages. COX-2, LPS, NF-kappaB, PG
2013 Temperature Effects of Sputtering of Langmuir-Blodgett Multilayers. AFM, LB, ToF-SIMS
2012 DHA and EPA reverse cystic fibrosis-related FA abnormalities by suppressing FA desaturase expression and activity. CF, DHA, EPA, LA
2012 Fish oil supplementation maintains adequate plasma arachidonate in cats, but similar amounts of vegetable oils lead to dietary arachidonate deficiency from nutrient dilution. EC, FA, LA, LCn-3
2011 Fundamental studies of molecular depth profiling using organic delta layers as model systems. DMPA
2011 Increased Delta5- and Delta6-desaturase, cyclooxygenase-2, and lipoxygenase-5 expression and activity are associated with fatty acid and eicosanoid changes in cystic fibrosis. DHA, DPA, EPA, LA, LNA
10  2011 Molecular depth profiling of buried lipid bilayers using C(60)-secondary ion mass spectrometry. AFM, DMPA, ToF-SIMS
11  2010 Quantitative analysis of phospholipids containing arachidonate and docosahexaenoate chains in microdissected regions of mouse brain. DHA, MRM
12  2007 Roles of vasoconstrictor prostaglandins, COX-1 and -2, and AT1, AT2, and TP receptors in a rat model of early 2K,1C hypertension. 8-Iso, Ang, COXs, MAP, PRA, TP-Rs, TX
13  2007 Synthesis, isomer characterization, and anti-inflammatory properties of nitroarachidonate. MS
14  2006 Fatty acid ethyl esters in meconium: are they biomarkers of fetal alcohol exposure and effect? DHA, FAEEs, GC/MS
15  2006 Recombinant factor VIIa reverses the inhibitory effect of aspirin or aspirin plus clopidogrel on in vitro thrombin generation. ADP, PRP, rFVIIa, TG
16  2006 Thrombin generation by activated factor VII on platelet activated by different agonists. Extending the cell-based model of hemostasis. CAT, COL, LT, PTG, rFVIIa, TG, TTP
17  2005 Abciximab does not inhibit the increase of thrombin generation produced in platelet-rich plasma in vitro by sodium arachidonate or tissue factor. ETG, GP, LT, PRP, PTG, TF, TG, TTP
18  2005 An integrative metabolism approach identifies stearoyl-CoA desaturase as a target for an arachidonate-enriched diet. DHA, EPA, FA, PC, PL, SCD1, SVD
19  2004 [Research and development of the free radical scavenger edaravone as a neuroprotectant]. BBB
20  2003 Cellular arachidonate-releasing function of novel classes of secretory phospholipase A2s (groups III and XII). PG
21  2002 Cellular arachidonate-releasing function and inflammation-associated expression of group IIF secretory phospholipase A2. ---
22  2002 Structural changes are induced in human neutrophil cytochrome b by NADPH oxidase activators, LDS, SDS, and arachidonate: intermolecular resonance energy transfer between trisulfopyrenyl-wheat germ agglutinin and cytochrome b(558). RET
23  2002 Valdecoxib does not impair platelet function. ADP, COX, NSAIDs
24  2001 Catalytic consumption of nitric oxide by 12/15- lipoxygenase: inhibition of monocyte soluble guanylate cyclase activation. LA, LOX
25  2001 High glucose and advanced glycation end products induce phospholipid hydrolysis and phospholipid enzyme inhibition in bovine retinal pericytes. AGEs, AT, CPT, CT, LDH
26  2000 Addition of eicosapentaenoic acid to gamma-linolenic acid-supplemented diets prevents serum arachidonic acid accumulation in humans. DGLA, EPA, GLA
27  2000 Effect of sodium arachidonate on thrombin generation through platelet activation--inhibitory effect of aspirin. ---
28  2000 Modification by arachidonic acid of extracellular adenosine metabolism and neuromodulatory action in the rat hippocampus. ---
29  2000 Modulation of arachidonate and docosahexaenoate in Morone chrysops larval tissues and the effect on growth and survival. DHA, EPA
30  1999 A phagocytic challenge with IgG-coated erythrocytes depresses macrophage respiratory burst and phagocytic function by different mechanisms. EIgG, PLA2, PMA
31  1999 Signaling mechanisms involved in the activation of arachidonic acid metabolism in human astrocytoma cells by tumor necrosis factor-alpha: phosphorylation of cytosolic phospholipase A2 and transactivation of cyclooxygenase-2. COX-2, cPLA2, JNK, MAP kinase, NF-kappaB, TNF-alpha
32  1998 Effect of replacing a high linoleate oil with a low linoleate, high alpha-linolenate oil, as compared with supplementing EPA or DHA, on reducing lipid mediator production in rat polymorphonuclear leukocytes. alpha-LnA, DHA, EPA, LA, PAF, PMN
33  1998 Effects of chroman derivatives on platelet aggregation induced by some aggregating agents in rabbits. ADP, PAF
34  1998 Influence of leukotrienes on in vitro growth of human mammary carcinoma cell line MCF-7. LT
35  1998 Interleukin 1beta decreases prostacyclin synthase activity in rat mesangial cells via endogenous peroxynitrite formation. 6-oxo-PGF1alpha, IL-1beta, PGE2, PGH2, PON, RMC
36  1998 [Alteration of fatty acid components of erythrocyte membrane and insulin resistance in diabetic patients]. FA, ISR
37  1997 Blockade of protein kinase C is involved in the inhibition by cycloheterophyllin of neutrophil superoxide anion generation. DHF, fMLP, PKA, PKC, PMA
38  1997 Evidence that 85 kDa phospholipase A2 is not linked to CoA-independent transacylase-mediated production of platelet-activating factor in human monocytes. CoA-IT, GPC, PAF, PLA2, rh
39  1997 Macrophage arachidonate release via both the cytosolic Ca(2+)-dependent and -independent phospholipases is necessary for cell spreading. cPLA2, PKC, PLA2
40  1996 Activation of cytosolic phospholipase A2 in permeabilized human neutrophils. FMLP, PLA2
41  1996 Membrane stabilizing, anti-oxidative interactions of propranolol and dexpropranolol with neutrophils. LPC, OZ, PAF, PLA2, PMA
42  1996 Regulatory effects of dietary n-3 and n-6 lipids on plasma and hepatic lipid levels, liver cell number and microsomal protein content in spontaneously hypertensive rats. DHA, EPA, LA
43  1995 Discordance between macrophage arachidonate metabolic phenotype and the expression of cytosolic phospholipase A2 and cyclooxygenase. COX, cPLA2, PLase
44  1994 CoA-independent transacylase activity is increased in human neutrophils after treatment with tumor necrosis factor alpha. CoA-IT, GPC, TNF
45  1994 Effect of inhibition of beta-oxidation on incorporation of [U-14C]palmitate and [1-14C]arachidonate into brain lipids. PA
46  1994 Effects of an antistroke agent MCl-186 on cerebral arachidonate cascade. ---
47  1994 Kinetics of prostacyclin synthesis in PGHS-1-overexpressed endothelial cells. PG, PGHS-1
48  1994 Prostaglandin E2 production by uterine stromal cell line UIII: regulation by estradiol and evidence of an ethanol action. PGE2
49  1993 An in vitro comparison of the effects of the prooxidative riminophenazines clofazimine and B669 on neutrophil phospholipase A2 activity and superoxide generation. LPC
50  1993 Differential changes of adrenoceptor- and muscarinic receptor-linked prostacyclin synthesis by the aorta and urinary bladder of the diabetic rat. ACh, AII, DM, PDBU, PKC, PLA2
51  1993 Enzymatic studies of lyso platelet-activating factor acylation in human neutrophils and changes upon stimulation. alkenyl-2-lyso-GPE
52  1992 Effects of oral soy phosphatidylcholine on phagocytosis, arachidonate concentrations, and killing by human polymorphonuclear leukocytes. LA, LTB4, PC, PMNL
53  1992 Kinetics of merthiolate-induced aggregation of human platelets. MT, PRP
54  1992 Role of protein kinase C in the regulation of prostaglandin synthesis in human endothelium. BAPTA-AM, HUVEC, PI, PKC, PLC, PMA
55  1992 The effects of beraprost Na, a stable prostacyclin analog, on animal models of stroke. SHRSP
56  1992 [Anti-thrombotic and anti-atherogenic action of eicosapentaenoic acid]. EPA, PDGF
57  1991 Protein kinase C promotes arachidonate mobilization through enhancement of CoA-independent transacylase activity in platelets. PMA
58  1990 Differential activation of protein kinase C alpha is associated with arachidonate release in Madin-Darby canine kidney cells. MDCK, PKC
59  1990 Dopamine inhibits the arachidonate and prolactin release stimulated by thyrotropin-releasing hormone through an islet-activating protein-sensitive GTP-binding protein in anterior pituitary cells. DA, IAP, PLA2, PRL
60  1990 Physiological and biochemical effects of bradykinin and lys-bradykinin in pituitary cells. BK, DA, LBK, PRL
61  1990 Platelet-activating factor (PAF) and PAF antagonists in asthma. BC, LTD4, PAF
62  1990 Production of thromboxanes by transformed lymphocytes--effect on heart contractility. CLL, RAJI, TX
63  1990 Trifluoperazine enhances accumulation and inhibits phosphohydrolysis of phosphatidate in thrombin-stimulated platelets. PA, PLA2, TFP
64  1989 Cutaneous inflammation: effects of hydroxy acids and eicosanoid pathway inhibitors on vascular permeability. 5-HETE
65  1989 Dual effects of cyclosporine A on arachidonate metabolism by peritoneal macrophages. Phospholipase activation and partial thromboxane-synthase blockage. 12-HETE, CsA, PG, TX
66  1989 Eicosanoid metabolism in cholesterol-enriched arterial smooth muscle cells: reduced arachidonate release with concomitant decrease in cyclooxygenase products. CE, cLDL, SMC
67  1989 The signal transduction systems and intracellular Ca2+ dynamics in arachidonate-induced platelet activation. ---
68  1989 Trifenagrel: a chemically novel platelet aggregation inhibitor. GI
69  1988 Diltiazem potentiates the inhibitory effect of aspirin on platelet aggregation. PAF
70  1988 Interference of eicosapentaenoic and docosahexaenoic acids with arachidonate-and U46619-induced platelet activation and desensitization. DCHA, EPA, TX
71  1987 A commentary on the inhibition by retinoids of leukotriene B4 production in leukocytes. LTB4, PDBu, PMN
72  1987 Active metabolism of phosphatidylethanolamine plasmalogen in stimulated platelets, analyzed by high performance liquid chromatography. HPLC, PC, PEP
73  1987 Polyunsaturated fatty acids augment free radical generation in tumor cells in vitro. EPA, GLA, LA, PUFAs
74  1987 Quantitative loss of individual eicosapentaenoyl-relative to arachidonoyl-containing phospholipids in thrombin-stimulated human platelets. EPA, PC, PE, PI, PS
75  1986 Differential effects of mepacrine, chloroquine and hydroxychloroquine on superoxide anion generation, phospholipid methylation and arachidonic acid release by human blood monocytes. CQ, HCQ, MNC, PC, PE, PKC, PL, SO, STZ
76  1986 Evidence for the mechanism by which garlic inhibits platelet aggregation. ---
77  1986 Isolation and effects of some ginger components of platelet aggregation and eicosanoid biosynthesis. ---
78  1986 Modulation of arachidonic acid metabolism in human endothelial cells by glucocorticoids. EC, PG
79  1986 Synergistic actions of paf-acether and sodium arachidonate in human platelet aggregation. 2. Unexpected results after aspirin intake. PRP
80  1985 Docosahexaenoic acid (C22:6 omega 3) and linoleic acid are anti-aggregatory, and alter arachidonic acid metabolism in human platelets. PGs
81  1985 Role of arachidonic acid metabolism in human platelet activation and irreversible aggregation. ---
82  1984 Sodium arachidonate induced in vitro polymorphonuclear leukocyte aggregation. CTB, LDH, PMNs
83  1984 The cyclo-oxygenase pathway in the avascular heart of the frog, Rana esculenta L. PLS
84  1983 Cardiovascular and sympathetic responses to chronic arachidonate in SHR and WKY rats. BP, HR, NE, SHR
85  1983 Familial and constitutional bleeding disorder due to platelet cyclo-oxygenase deficiency. TX
86  1983 Patterns of prostaglandin synthesis and degradation in isolated superficial and proliferative colonic epithelial cells compared to residual colon. PG
87  1983 Uterine arterial responses to arachidonate in pregnant and nonpregnant rabbits. PG
88  1982 Calcium-dependent stimulation of renal medullary prostaglandin synthesis by furosemide. iPGE
89  1982 Effect of platelet-generated thromboxane on contractions of the pregnant rat uterus. PRP, TXA2, WP
90  1982 Platelet hyperaggregability in ischemic cerebrovascular disease and effects of aspirin. CVD
91  1981 Effects of vasopressin and urea on Ca2+-calmodulin-dependent renal prostaglandin E. AH, IM, TFP
92  1981 Renal inner medullary prostaglandin synthesis. A calcium-calmodulin-dependent process suppressed by urea. AH, IM, iPGE, TFP
93  1981 The effect of cigarette smoke on the metabolism of arachidonic acid to myotropic compounds in rat and hamster isolated lungs. BCA, RSS